# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months ...
https://www.reuters.com/business/aerospace-defense/boeing-brief-european-regulators-new-production-plans-after-737-max-panel-20...
- Reuters Citing Sources
https://www.reuters.com/world/us/trump-reviews-plan-halt-us-military-aid-ukraine-unless-it-negotiates-peace-with-2024-06-25/Two...
Novavax's JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3GAITHERSBURG, Md., Ju...
GSK Plc has lost out to Pfizer Inc. on a contract to supply millions of doses of its blockbuster RSV vaccine to the UK in a set...
https://ec.europa.eu/commission/presscorner/detail/en/ip_24_3433